Cleaning validation is the documented process of proving that cleaning procedures for manufacturing equipment consistently reduce residues to predetermined acceptable levels. It ensures that product carryover, cleaning agent residues, and microbial contamination do not compromise subsequent batches. Cleaning validation is a regulatory requirement for all multi-purpose pharmaceutical facilities.
What Is Cleaning Validation?
Cleaning validation demonstrates that a defined cleaning procedure effectively removes the previous product, cleaning agents, and microbial bioburden from equipment surfaces. The worst-case approach is used, selecting the hardest-to-clean product, the most difficult equipment geometry, and the maximum hold time before cleaning. Acceptance criteria are established based on toxicological and pharmacological risk assessment.
Regulatory Framework
EU GMP Annex 15 requires cleaning validation protocols and reports as part of the overall validation program. The FDA’s 1993 guide and the PDA Technical Report 29 provide detailed methodology. ICH Q9 Quality Risk Management principles are applied to determine the scope and extent of cleaning validation, including the selection of worst-case products.
Key Principles
Limits for product residues are typically calculated using three criteria: no more than 0.1% of the lowest therapeutic dose carried into the maximum daily dose of the next product, no more than 10 ppm of any residue in the next product, and visual cleanliness. Analytical methods used for swab and rinse sampling must be validated to the required quantitation limits. Cleaning validation includes three consecutive successful runs per surface per procedure.
Applications
Cleaning validation applies to oral solid dosage forms, sterile manufacturing, topical products, and biologics. Dedicated equipment for highly potent compounds may require different approaches, including dedicated facilities or closed processing systems. Campaign-based manufacturing requires assessment of the maximum campaign duration before cleaning is needed.
Conclusion
Cleaning validation is a critical GMP activity that directly protects patient safety by preventing cross-contamination. A robust cleaning validation program, supported by risk assessment and validated analytical methods, satisfies regulatory expectations and enables flexible, multi-product manufacturing. Periodic cleaning verification ensures that validated states are maintained.
